Showing results (11-20 of 111) with videos related to
Sort By:
Pageof 12
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 3, 2020
European Stakeholder Learnings Regarding Biosimilars: Part I-Improving Biosimilar Understanding and AdoptionLiese Barbier, Steven Simoens, Arnold G Vulto, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|April 2, 2020
Biosimilar Pegfilgrastim: Improving Access and Optimising Practice to Supportive Care that Enables CurePaul Cornes, Pere Gascon, Arnold G Vulto, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|December 4, 2019
Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!Binita Dutta, Isabelle Huys, Arnold G Vulto, et al.Frontiers in Pharmacology|January 2, 2023
Evaluating the benefits of TNF-alfa inhibitor biosimilar competition on off-patent and on-patent drug markets: A Southern European analysisTeresa Barcina Lacosta, Arnold G Vulto, Isabelle Huys, et al.Frontiers in Medicine|January 27, 2023
An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and SpainTeresa Barcina Lacosta, Arnold G Vulto, Isabelle Huys, et al.Journal of Market Access & Health Policy|April 15, 2020
Economic evaluation of biosimilars for reimbursement purposes - what, when, how?Evelien Moorkens, Hannah Broux, Isabelle Huys, et al.Expert Opinion on Biological Therapy|May 26, 2025
Evolving global regulatory landscape for approval of biosimilars: current challenges and opportunities for convergenceElif Car, Liese Barbier, Isabelle Huys, et al.Applied Health Economics and Health Policy|August 16, 2022
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological MedicinesYannick Vandenplas, Steven Simoens, Florian Turk, et al.Frontiers in Pharmacology|July 29, 2022
Biosimilar Use and Switching in Belgium: Avenues for Integrated PolicymakingLiese Barbier, Steven Simoens, Paul Declerck, et al.Fundamental & Clinical Pharmacology|September 24, 2005
Population pharmacokinetics of ketanserin in pre-eclamptic patients and its association with antihypertensive responseLidwien M Hanff, Wil Visser, Erik A P Steegers, et al.Pageof 12